Get started
Author

Jennifer L. Leiting

Observed names: J. Leiting, J.L. Leiting, JENNIFER L. LEITING, Jennifer L Leiting, Jennifer Leiting, Leiting J., Leiting, Jennifer, Leiting, Jennifer L.
Institution: Mayo Clinic
ORCID: 0000-0002-5784-7937
Observed ORCID: 0000-0002-5784-7937
OpenAlex ID: A5013823935
Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features
2019 · John R. Bergquist, Jennifer L. Leiting, et al. · Surgery · 149
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
2022 · Amro M. Abdelrahman, Ajit H. Goenka, et al. · Journal of the National Comprehensive Cancer Network · 63
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
2020 · Elizabeth Lenkiewicz, Smriti Malasi, et al. · Cancer Research · 57
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2021 · Gadi Lalazar, David Requena, et al. · Cancer Discovery · 47
PDF
Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
2019 · Eliza W. Beal, Ahmed Ahmed, et al. · The American Journal of Surgery · 44
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
2020 · Eliza W. Beal, Lorena P. Suarez-Kelly, et al. · Journal of Clinical Medicine · 40
PDF
Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative
2020 · Jennifer L Leiting, Jordan M Cloyd, et al. · World Journal of Gastrointestinal Oncology · 34
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative
2019 · Nick C. Levinsky, Mackenzie C. Morris, et al. · Journal of Gastrointestinal Surgery · 34
Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study
2019 · Tiffany C. Lee, Koffi Wima, et al. · Journal of Gastrointestinal Surgery · 32
Advancements and challenges in treating advanced gastric cancer in the West
2019 · Jennifer L Leiting, Travis E Grotz · World Journal of Gastrointestinal Oncology · 32
PDF
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
2019 · Jason T. Wiseman, Charles Kimbrough, et al. · Annals of Surgical Oncology · 31
Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens
2019 · Matthew C. Hernandez, John R. Bergquist, et al. · Journal of Gastrointestinal Surgery · 30
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
2020 · Jennifer L. Leiting, Stephen J. Murphy, et al. · JHEP Reports · 27
PDF
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative
2019 · Adriana C. Gamboa, Mohammad Y. Zaidi, et al. · Annals of Surgical Oncology · 27
A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies
2020 · Jason T. Wiseman, Sherif Abdel-Misih, et al. · Surgical Oncology · 26
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative
2020 · Adriana C. Gamboa, Rachel M. Lee, et al. · Annals of Surgical Oncology · 26
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative
2019 · Rachel M. Lee, Mohammad Y. Zaidi, et al. · Clinical Colorectal Cancer · 23
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study
2019 · Nikhil V. Kotha, Joel M. Baumgartner, et al. · Annals of Surgical Oncology · 21
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study
2020 · Benjamin D. Powers, Seth Felder, et al. · Annals of Surgical Oncology · 19
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative
2019 · Mohammad Y. Zaidi, Rachel M. Lee, et al. · Annals of Surgical Oncology · 19
Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment
2018 · Matthew C. Hernandez, Lin Yang, et al. · Translational Oncology · 19
PDF
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
2020 · Mansi Arora, James M. Bogenberger, et al. · Cancer Chemotherapy and Pharmacology · 18
Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
2019 · Jennifer L. Leiting, Matthew C. Hernandez, et al. · Scientific Reports · 17
PDF
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
2022 · Eliza W. Beal, Shruthi Srinivas, et al. · Annals of Surgical Oncology · 16
Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers
2021 · Mansi Arora, James M. Bogenberger, et al. · Hepatology · 16
PDF
Works count: 101
Citation count: 1,085
H-index: 19
I10-index: 37
Year
Topic
Type